Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012.
Pegylated interferons: a nurses' review of a novel multiple sclerosis therapy.
Imaging in multiple sclerosis and related disorders.
Neuroinflammation. Contemporary anti-inflammatory treatment approaches.
Experience of gratitude, awe and beauty in life among patients with multiple sclerosis and psychiatric disorders.
Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
Claudin Proteins And Neuronal Function.
NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG.
Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature.
Subacute sclerosing panencephalitis presenting as neuromyelitis optica.
The radiologically isolated syndrome dilemma: just an incidental radiological finding or presymptomatic multiple sclerosis?
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis.
Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review.
Biotherapeutics for the treatment of multiple sclerosis: hopes and hazards.
Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient.
IFNγ Influences Type I Interferon Response and Susceptibility to Theiler's Virus-Induced Demyelinating Disease.
Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis.
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.
The innate immune system in demyelinating disease.
Purkinje cell dysfunction and delayed death in plasma membrane calcium ATPase 2-heterozygous mice.
Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis.
The Blood-Brain Barrier in Multiple Sclerosis: MicroRNAs as Key Regulators.
Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis.

Pages